Stock listing

NASDAQ:THRD Third Harmonic Bio Inc. Stock

Follow Third Harmonic Bio Inc. into a list and get an email when it puts out news.

Delisted NASDAQ:THRD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:THRD
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Third Harmonic Bio Inc. on 6ix

Decks
6 decks · latest Jun 12, 2025

Decks

DeckKindSlidesDate
Investor Presentation (June 2025)Investor deck38 slidesJun 12, 2025
Investor Presentation (March 2025)Investor deck30 slidesMar 11, 2025
Corporate Update (May 2024)Corporate update21 slidesMay 15, 2024
Investor Presentation (January 2024)Investor deck18 slidesJan 4, 2024
Investor Presentation (July 2023)Investor deck17 slidesJul 25, 2023
Investor Presentation (October 2022)Investor deck20 slidesOct 11, 2022

Open Decks

Shareholders

HolderSharesValueAs of
Rhumbline Advisers19,980US$107KSep 30, 2026
Caldwell Sutter Capital, Inc.1,000Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert J Perez
Other companies: Rapport Therapeutics, Inc. (Director · Since at least Nov 7, 2024); Immunocore Holdings plc (Director · Jan 2, 2024 – Jan 2, 2024 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 22, 2023 · Past); Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jun 14, 2019 · Past); Spark Therapeutics Inc (Director · Jan 3, 2018 – Dec 17, 2019 · Past); Larimar Therapeutics, Inc. (Director · Sep 24, 2015 – Jun 26, 2019 · Past); Decoy Therapeutics Inc. (Director · Sep 2, 2015 – Jul 26, 2017 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2017 · Past); AMAG Pharmaceuticals Inc (Director · Jan 26, 2009 – May 16, 2019 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past)
Director · Sep 14, 2022 – Mar 6, 2023 · Past
Mark Iwicki
Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past)
Director · Since at least Sep 14, 2022
Edward R. Conner
Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since at least Apr 23, 2026); Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Audentes Therapeutics Inc (SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past)
Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past
David Bonita
Other companies: Windward Bio Group AG (Director · Since at least Nov 16, 2026); ImageneBio, Inc. (Director · Since at least Jul 25, 2025); Prelude Therapeutics Incorporated (Director · Since at least Jun 12, 2025)
Director · Since at least Aug 11, 2025
Geoff McDonough
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Surface Oncology Inc (Director · Jun 5, 2019 – Jun 8, 2021 · Past)
Director · Mar 27, 2024 – Mar 27, 2024 · Past
Christopher Dinsmore
Other companies: Kronos Bio Inc (Chief Scientific Officer · Oct 8, 2020 – Jan 4, 2024 · Past)
Chief Scientific Officer · May 16, 2024 – Jan 15, 2025 · Past
Adrian S RayChief Scientific Officer · Sep 14, 2022 – Mar 6, 2023 · Past
Dennis DeanChief Nonclinical Dev. Officer · May 16, 2024 – Jan 15, 2025 · Past
Jennifer DittmanChief Operating Officer · May 16, 2024 – Jan 15, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Third Harmonic Bio Inc.